Literature DB >> 8616845

Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy.

H H Schmeiser1, C A Bieler, M Wiessler, C van Ypersele de Strihou, J P Cosyns.   

Abstract

A unique type of rapidly progressive renal fibrosis, designated Chinese herbs nephropathy (CHN), has been described in young Belgian women who had followed a slimming regimen including recently introduced Chinese herbs (Stephania tetrandra and Magnolia officinalis). Aristolochic acid (AA), a known nephrotoxin and carcinogen, was suspected as its causal factor. To substantiate this hypothesis, renal tissue from five patients with CHN and six patients with other renal diseases was analyzed for the presence of AA-derived DNA adducts, a described biomarker of AA exposure associated with its carcinogenic and mutagenic activity. Using the 32P-postlabeling method, a major distinct DNA adduct spot was found in all five cases of CHN and identified by cochromatographic analyses with authentic markers as the deoxyadenosine adduct of AA-I [7-(deoxyadenosin-N6-yl)-aristolactam I], the major component of the plant extract AA. This DNA adduct was absent in the six control cases. The 7-(deoxyadenosin-N6-yl)-aristolactam I adduct levels in CHN ranged from 0.7 to 5.3/10(7) nucleotides. Our data demonstrate that AA is implicated in CHN. They suggest a mechanism for the urothelial atypia and cancers observed in this disease and raise the possibility that a DNA mutation is responsible for the kidney-destructive fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616845

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Effect of base sequence context on the conformational heterogeneity of aristolactam-I adducted DNA: structural and energetic insights into sequence-dependent repair and mutagenicity.

Authors:  Preetleen Kathuria; Purshotam Sharma; Stacey D Wetmore
Journal:  Toxicol Res (Camb)       Date:  2015-10-23       Impact factor: 3.524

3.  Aristolochic acid I metabolism in the isolated perfused rat kidney.

Authors:  Horacio A Priestap; M Cecilia Torres; Robert A Rieger; Kathleen G Dickman; Tomoko Freshwater; David R Taft; Manuel A Barbieri; Charles R Iden
Journal:  Chem Res Toxicol       Date:  2011-12-14       Impact factor: 3.739

Review 4.  Analysis of the adverse reactions induced by natural product-derived drugs.

Authors:  Zhi-Ping Zeng; Jian-Guo Jiang
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

5.  Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2.

Authors:  Marie Stiborová; Katerina Levová; Frantisek Bárta; Zhanquan Shi; Eva Frei; Heinz H Schmeiser; Daniel W Nebert; David H Phillips; Volker M Arlt
Journal:  Toxicol Sci       Date:  2011-11-15       Impact factor: 4.849

6.  Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.

Authors:  Xavier Castells; Sandra Karanović; Maude Ardin; Karla Tomić; Evanguelos Xylinas; Geoffroy Durand; Stephanie Villar; Nathalie Forey; Florence Le Calvez-Kelm; Catherine Voegele; Krešimir Karlović; Maja Mišić; Damir Dittrich; Igor Dolgalev; James McKay; Shahrokh F Shariat; Viktoria S Sidorenko; Andrea Fernandes; Adriana Heguy; Kathleen G Dickman; Magali Olivier; Arthur P Grollman; Bojan Jelaković; Jiri Zavadil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-17       Impact factor: 4.254

Review 7.  p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.

Authors:  Neda Slade; Ute M Moll; Branko Brdar; Arijana Zorić; Bojan Jelaković
Journal:  Mutat Res       Date:  2009-02-04       Impact factor: 2.433

Review 8.  Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.

Authors:  Jean-Pierre Cosyns
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

10.  DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells.

Authors:  Sivaprasad Attaluri; Radha R Bonala; In-Young Yang; Mark A Lukin; Yujing Wen; Arthur P Grollman; Masaaki Moriya; Charles R Iden; Francis Johnson
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.